110 related articles for article (PubMed ID: 22768080)
1. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
[TBL] [Abstract][Full Text] [Related]
2. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract][Full Text] [Related]
3.
Wang SS; Zhai GQ; Chen G; Huang ZG; Zhang Y; Zhang LJ; Dang YW; Li SH; Yan HB
Cancer Biother Radiopharm; 2023 Nov; 38(9):650-662. PubMed ID: 35704039
[No Abstract] [Full Text] [Related]
4. Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin.
Song Z; Wang Y; Li C; Zhang D; Wang X
PLoS One; 2015; 10(5):e0127599. PubMed ID: 25993398
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation.
Sun H; Shang J; Liu X; Ren S; Hu S; Wang X
BMC Cancer; 2024 Apr; 24(1):432. PubMed ID: 38589831
[TBL] [Abstract][Full Text] [Related]
6. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract][Full Text] [Related]
7. Arsenic disulfide promoted the demethylation of
Chen C; Wang L; Liu Y; Du S; Teng Q
PeerJ; 2024; 12():e17363. PubMed ID: 38766487
[TBL] [Abstract][Full Text] [Related]
8. Targeting HDACs for diffuse large B-cell lymphoma therapy.
Wu C; Song Q; Gao S; Wu S
Sci Rep; 2024 Jan; 14(1):289. PubMed ID: 38168914
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development.
Song T; He N; Hao Z; Yang Y
J Cell Physiol; 2023 Jun; 238(6):1308-1323. PubMed ID: 36960713
[TBL] [Abstract][Full Text] [Related]
10. FAT1 inhibits the proliferation of DLBCL cells via increasing the m
Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N
Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965
[TBL] [Abstract][Full Text] [Related]
11. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
[TBL] [Abstract][Full Text] [Related]
12. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease.
Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H
Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969
[TBL] [Abstract][Full Text] [Related]
13. Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma.
Liu B; Zhao X; Zhang S; Li Q; Li X; Huang D; Xia J; Ma N; Duan Y; Zhang X; Rao J
Leukemia; 2024 Feb; 38(2):351-364. PubMed ID: 38195819
[TBL] [Abstract][Full Text] [Related]
14. Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell Lymphoma.
Kawade G; Kurata M; Matsuki Y; Fukuda S; Onishi I; Kinowaki Y; Watabe S; Ishibashi S; Ikeda M; Yamamoto M; Ohashi K; Kitagawa M; Yamamoto K
Lab Invest; 2024 Apr; 104(4):102027. PubMed ID: 38311062
[TBL] [Abstract][Full Text] [Related]
15. IL-1R8 expression in DLBCL regulates NK cell recruitment and influences patient prognosis.
Yu M; Zhang Q; Wan L; Wang S; Zou L; Chen Z; Li F
Funct Integr Genomics; 2023 Nov; 23(4):328. PubMed ID: 37907630
[TBL] [Abstract][Full Text] [Related]
16. TNF-α-Induced miR-21-3p Promotes Intestinal Barrier Dysfunction by Inhibiting MTDH Expression.
Jiang Z; Yang F; Qie J; Jin C; Zhang F; Shen J; Zhang L
Front Pharmacol; 2021; 12():722283. PubMed ID: 34483933
[TBL] [Abstract][Full Text] [Related]
17. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway.
Zhao H; Xiang G; Shao T; Wang M; Dai W
Open Life Sci; 2023; 18(1):20220726. PubMed ID: 37854321
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of USP25 promotes progression of human diffuse large B-cell lymphoma through blocking the ubiquitinated degradation of MDM2.
Yang H; Liu Y; Yang J; Zhang Q; Wang H; Chen Y; Zhou K
Biochem Biophys Res Commun; 2023 Oct; 676():21-29. PubMed ID: 37480689
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL.
Bhalla K; Jaber S; Nahid M N; Underwood K; Beheshti A; Landon A; Bhandary B; Bastian P; Evens AM; Haley J; Polster B; Gartenhaus RB
Sci Rep; 2018 Jan; 8(1):744. PubMed ID: 29335581
[TBL] [Abstract][Full Text] [Related]
20. The Roles of IRF-8 in Regulating IL-9-Mediated Immunologic Mechanisms in the Development of DLBCL: A State-of-the-Art Literature Review.
Cai M; Chen N
Front Oncol; 2022; 12():817069. PubMed ID: 35211408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
